Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gabriel Gras is active.

Publication


Featured researches published by Gabriel Gras.


American Journal of Reproductive Immunology | 1997

Immune Suppression and Th1/Th2 Balance in Pregnancy Revisited: A (Very) Personal Tribute to Tom Wegmann

Gérard Chaouat; Juliette Tranchot Diallo; Jean Luc Voluménie; Elisabeth Menu; Gabriel Gras; Geneviéve Delage; Barbara Mognetti

PROBLEM: The paradigm of local suppression necessary to understand the survival of the fetal allograft is often compared with the host‐tumor relationship.


American Journal of Reproductive Immunology | 1997

Modulations of Cytokine Expression in Pregnant Women

Juliette Tranchot-Diallo; Gabriel Gras; Olivier Benveniste; Dominique Marcé; Pierre Roques; Dominique Dormont; Françoise Parnet-Mathieu; Jacques Milliez; Gérard Chaouat

PROBLEM: Although the overall anti‐infectious and anti‐parasitic immunity of parous women appears normal, several aspects of maternal cell‐mediated and humoral immunity are altered during pregnancy. This has been suggested to occur via preferential local and systemic secretion of Th‐2 type cytokines, which down‐regulate or prevent secretion/action of Th‐1 type cytokines, in animals as well as in humans.


Neuropathology and Applied Neurobiology | 2002

Expression of excitatory amino acid transporter‐2 (EAAT‐2) and glutamine synthetase (GS) in brain macrophages and microglia of SIVmac251‐infected macaques

F. Chrétien; Anne-Valérie Vallat-Decouvelaere; C. Bossuet; A.‐C. Rimaniol; R. Le Grand; G. Le Pavec; Christophe Créminon; Dominique Dormont; Françoise Gray; Gabriel Gras

Na+‐dependent transporters for glutamate (excitatory amino acid transporters, EAATs) clear extracellular glutamate in the brain and prevent excitotoxic neuronal damage. Glutamine synthetase (GS) provides metabolic support for neurones by producing the neurotrophic amino acid glutamine. EAAT and GS expression has recently been demonstrated in macrophages and microglial cells inu2003vitro, and in two models of acute inflammation inu2003vivo. This observation might modify our current understanding of brain inflammation, which considers activated microglia and brain macrophages as the main neurotoxic cells through their production of a variety of neurotoxins, including glutamate. EAAT and GS expression by these cells would entail neuroprotective and neurotrophic properties, counterbalancing the deleterious consequences of microglial activation.


Brain Pathology | 2006

Regulated Expression of Sodium-dependent Glutamate Transporters and Synthetase: a Neuroprotective Role for Activated Microglia and Macrophages in HIV Infection?

Gabriel Gras; Fabrice Chrétien; Anne-Valérie Vallat-Decouvelaere; Gwenaelle Le Pavec; Fabrice Porcheray; Christophe Bossuet; Cathie Léone; Patricia Mialocq; Nathalie Dereuddre-Bosquet; Pascal Clayette; Roger Le Grand; Christophe Créminon; Dominique Dormont; Anne-Cécile Rimaniol; Françoise Gray

It is now widely accepted that neuronal damage in HIV infection results mainly from microglial activation and involves apoptosis, oxidative stress and glutamate‐mediated neurotoxicity. Glutamate toxicity acts via 2 distinct pathways: an excitotoxic one in which glutamate receptors are hyperactivated, and an oxidative one in which cystine uptake is inhibited, resulting in glutathione depletion and oxidative stress. A number of studies show that astrocytes normally take up glutamate, keeping extracellular glutamate concentration low in the brain and preventing excitotoxicity. This action is inhibited in HIV infection, probably due to the effects of inflammatory mediators and viral proteins. Other in vitro studies as well as in vivo experiments in rodents following mechanical stimulation, show that activated microglia and brain macrophages express high affinity glutamate transporters. These data have been confirmed in chronic inflammation of the brain, particularly in SIV infection, where activated microglia and brain macrophages also express glu‐tamine synthetase. Recent studies in humans with HIV infection show that activated microglia and brain macrophages express the glutamate transporter EAAT‐1 and that expression varies according to the disease stage. This suggests that, besides their recognized neurotoxic properties in HIV infection, these cells also have a neuroprotective function, and may partly make up for the inhibited astrocytic function, at least temporarily. This hypothesis might explain the discrepancy between microglial activation which occurs early in the disease, and neuronal apoptosis and neuronal loss which is a late event. In this review article, we discuss the possible neuro‐protective and neurotrophic roles of activated microglia and macrophages that may be generated by the expression of high affinity glutamate transporters and glutamine synthetase, 2 major effectors of glial glutamate metabolism, and the implications for HIV‐induced neuronal dysfunction, the underlying cause of HIV dementia.


FEBS Letters | 1996

Mechanisms of opsonized HIV entry in normal B lymphocytes

Christophe Legendre; Gabriel Gras; Roman Krzysiek; Pierre Galanaud; Yolande Richard; Dominique Dormont

Using our in vitro model of normal B cell infection that functions with low doses of HIV but requires virus opsonization by seropositive patient serum, and complement, we analyzed what receptors allowed virus entry. Here, we show that HIV infection of B cells occurs through 2 major receptors: the CD4 antigen and the CR1/CR2 complex. These 2 pathways work independently since a complete inhibition of virus entry requires both CD4 and CD21/CD35 blockade on CD4dim tonsillar B cells whereas only the latter is critical on CD4‐negative B cells.


American Journal of Reproductive Immunology | 1998

Neutralizing Antibodies and Complement-Mediated, Antibody-Dependent Enhancement (C'-ADE) of Human Immunodeficiency Virus Infection in Its Vertical Transmission

Gabriel Gras; Véronique Beyssen; Juliette Tranchot-Diallo; Dominique Dormont; Françoise Parnet-Mathieu; Géraud Lasfargues; Christian Courpotin

PROBLEM: Mother‐to‐child transmission is a major route for the spread of human immunodeficiency virus (HIV) worldwide. Our understanding of its mechanisms and parameters is still limited. Among the factors possibly involved in virus passage determination are the level and quality of antiviral humoral response.


Molecular Immunology | 2005

Macrophages and HIV-1: dangerous liaisons

Alessia Verani; Gabriel Gras; Gianfranco Pancino


International Immunology | 1998

CD80 expression is decreased in hyperplastic lymph nodes of HIV+ patients.

Christophe Legendre; Martine Raphael; Gabriel Gras; Eric A. Lefevre; Jean Feuillard; Dominique Dormont; Yolande Richard


/data/revues/00353787/016008-9/1_13/ | 2008

Société Française de Neuropathologie

Françoise Gray; Fabrice Chrétien; A.V. Decouvelaere; G Le Pavec; Dominique Dormont; Jacqueline Mikol; Gabriel Gras


Revue Neurologique | 2004

Expression du transporteur de haute affinité du glutamate EAAT-1 par les cellules macrophagiques et microgliales activées dans les maladies à prions

Françoise Gray; Fabrice Chrétien; A.V. Decouvelaere; G. Le Pavec; Dominique Dormont; Jacqueline Mikol; Gabriel Gras

Collaboration


Dive into the Gabriel Gras's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jacques Martal

Institut national de la recherche agronomique

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Pascal Clayette

University of New South Wales

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lin Hui

University of Alberta

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge